Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on November 13, 2013, by Lexaria Corp. (Lexaria Bioscience Corp.), a Nevada corporation. The report details the entry into a material definitive agreement and the creation of a direct financial obligation regarding the refinancing of existing debt.
Key Financial Metrics and Debt Terms
The filing does not provide specific revenue, profit, cash flow, or margin figures. It focuses exclusively on the restructuring of debt maturing in December 2013 with lenders including CAB Financial Services Ltd., David DeMartini, and Emerald Atlantic LLC. Key terms of the amended agreement include:
- Interest Rate: 18% per annum on the declining balance, payable monthly in arrears.
- Term: Converted to a one-year term loan effective December 1, 2013, with full principal due December 1, 2014.
- Principal Repayment Schedule:
- Standard Scenario: Ten (10) monthly payments of 1/10th of the principal, beginning March 1, 2014.
- Performance Scenario: If the PP F12-7 well produces an average of 100 barrels per day in its first 30 days, the schedule accelerates to eight (8) monthly payments of 1/8th of the principal.
- Collateral: Lenders receive a lien on capital investments exceeding $50,000 and a pro-rata portion of net revenue from the new 12-7 well (based on a denominator of $930,000).
Material Changes
The primary material change is the extension of repayment terms for debt that was previously due to mature in December 2013. The 2012 Amendment to the agreements was extinguished upon the effectiveness of this new Second Amendment Agreement.
Outlook, Risks, and Contingencies
The repayment schedule is contingent upon the production performance of the newly drilled PP F12-7 well. Failure to meet the 100 bbls/day average production target in the first 30 days will result in a longer repayment period (10 months vs. 8 months). Additionally, the agreement imposes a lien on future capital investments exceeding $50,000, which may restrict future capital deployment without lender consent.
Investor Verification Checklist
- Verify the total outstanding principal amount owed to the lenders as of November 13, 2013, which is not explicitly stated in this filing.
- Confirm the production status of the PP F12-7 well to determine if the accelerated 8-month repayment schedule applies.
- Review the company's liquidity position to assess its ability to service the 18% interest payments starting January 1, 2014.
- Examine the pro-rata revenue sharing terms regarding the 12-7 well to understand the impact on future cash flows.